Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication discontinuation in panic disorder.

J C Ballenger1

  • 1Department of Psychiatry and Behavioral Sciences, Institute of Psychiatry, Medical University of South Carolina, Charleston.

The Journal of Clinical Psychiatry
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From the benches to the trenches : training residents to provide emergency outreach services-a public/academic project.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Vagus nerve stimulation: a new form of therapeutic brain stimulation.

CNS spectrums·2008
Same author

Consensus statement on depression, anxiety, and cardiovascular disease.

The Journal of clinical psychiatry·2002
Same author

Consensus statement on depression, anxiety, and functional gastrointestinal disorders.

The Journal of clinical psychiatry·2002
Same author

Consensus statement on depression, anxiety, and oncology.

The Journal of clinical psychiatry·2002
Same author

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.

Journal of general internal medicine·2002
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Discontinuing panic disorder medication requires careful consideration of timing and strategies to prevent relapse or withdrawal. More long-term studies are needed to determine optimal discontinuation protocols for sustained patient wellness.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • Current panic disorder pharmacotherapy involves antidepressants or benzodiazepines for 3-12 months.
  • Optimal timing for medication discontinuation in panic disorder remains undetermined.

Purpose of the Study:

  • To review appropriate and inappropriate reasons for discontinuing panic disorder medications.
  • To discuss optimal timing, outcomes, and strategies for medication cessation.
  • To examine long-term outcomes in patients treated for panic disorder.

Main Methods:

  • Literature review and synthesis of available data on panic disorder pharmacotherapy.
  • Discussion of discontinuation outcomes: wellness, relapse, rebound, and withdrawal.
  • Analysis of dosage tapering strategies to mitigate adverse effects.

Related Experiment Videos

Main Results:

  • Preliminary understanding exists for acutely treated panic disorder patients.
  • Long-term outcomes data are limited.
  • Various factors influence discontinuation success, including patient response and medication type.

Conclusions:

  • Additional long-term follow-up studies are essential for establishing evidence-based discontinuation guidelines.
  • Current data suggest a need for individualized approaches to medication cessation in panic disorder.
  • Further research is required to fully understand the long-term course and management of panic disorder post-treatment.